Aronia leaves have been reported to contain a variety of physiologically active substances such as chlorogenic acid, its isomers, caffeic acid, quercetin 3-O-glucopyranoside and rutin [4] .
In particular, aronia young leaves contain a variety of phenolic compounds, such as caffeic acid, neochlorogenic acid and chlorogenic acid, compared to old leaves [8] . In some published studies, there is evidence that leaves of plants have physiological potency over fruit [9] . Denev et al. [10] reported aronia leaf extract contains a combination of antioxidant and strongly inhibited peroxyl radical formation in vitro with the same order of that for 毩 -tocophenol and significantly reduced CCl 4 -induced hepatic lipid peroxidation in vivo. In addition, streptozotocin was administered to rats to induce diabetes mellitus, and then it was confirmed that blood glucose was decreased at a significant level when the exract of aronia leaf was consumed [11] . Aronia leaves have been studied and reported to be effective in the prevention and treatment of cancer, leukemia and other chronic diseases [9] . Aronia leaf extract is known to be involved in the death of human leukemia cell line, HL60 cell and human promyelocytic leukemia cells, which is thought to be due to the action of polyphenol compounds contained in the extract of aronia leaf [9] .
Inflammation, which occurs as a tissue damage or as an early symptom of infection, initially occurs locally, but spreads to the surroundings over time [12] . The immune response is promoted by bacterial products and substances such as endogenous toxins or lipopolysaccharide. Previously published studies have shown that MMPs act as regulators in both increasing or decreasing inflammation [13] . In general, MMPs are known to increase in diseases where tissue damage or inflammation occurs, and to break down proteins and regulate cytokine/chemokine activity in the body. There is increasing evidence that it works in inflammation to regulate the inflow of white blood cells [13] [14] [15] . Epidemiologic studies show that many cancers such as lung, stomach, colon, bladder cancers are associated with microbial infection and these cancers and inflammation are related by epidemiology, histopathology, inflammatory profiles [16] [17] [18] . To study the inflammatory response, Raw 264.7 cells are generally treated with lipopolysaccharides (LPS) known to cause inflammation, which is widely used and evaluated as the most reliable method to date. LPS, called endotoxin, is a macromolecule composed of lipids and polysaccharides. Raw 264.7 cells are able to predict the extent of inflammation when stimulated with nitric oxide (NO) synthase secretion by measuring the amount of NO produced at that time [19, 20] .
In this study, the effect of aronia leaf extract on cancer cell metastasis was investigated by measuring the degree of inhibition of cancer cell migration and MMP-2/-9 and MT-1 MMP expression after treatment of aronia leaf extract in SK-Hep1 cancer cells. Raw 264.7 cells were treated with LPS to induce inflammation, and then treated with different concentrations of aronia leaf extract.
The amount of inflammation was measured to evaluate the antiinflammatory effect of aronia leaf.
Materials and methods

Chemicals
Cell culture supplies and chemicals were purchased from Sigma 
Aronia leaf extraction
Aronia leaves were used in the experiment by receiving leaves of 'Nero' varieties harvested in June at aroina farm in Korea. The leaves were washed in flowing water, frozen at -80 曟 for 24 h, then placed in a freeze dryer and dried for 2 d. The dried sample was put into a food grinder and made into a fine powder and stored at -80 曟 . The samples were extracted as follows; The powder sample (5 g) was mixed with 125 mL of 80% ethanol and shaken for 2 h in a 85 曟 water bath to extract the bioactive substances. This procedure was repeated three times. The supernatant was collected separately from the mixture and filtered through Whatman #2 filter paper under the vaccum. The extracted and filtered samples were evaporated under the vacuum at 40 曟 using a rotary evaporator. After evaporation, 50 mL of water was added to the sample to completely dissolve the sample. The sample was then lyophilized to prepare powder, which was then stored at -20 曟 for subsequent experiments. 
MTT assay
NO determination
In a 96-well plate, Raw 264.7 cells (at a concentration of 5 伊 10 5 cell/ well) were plated and stabilized. After the medium was removed and LPS was dissolved in fresh medium at a concentration of 2 mg/mL, 100 µL was added to each well. After 1 hour of incubation, different concentrations of aronia leaf extract (50-200 µg/mL) were added.
Then, the media were collected and used for NO determination after 12 hours of incubation. Since NO production is directly correlated with the amount of nitrite concentration in the medium, the amount of nitrite was calculated by Griess reaction in this experiment. After adding 50 µL of the Griess reagent to 50 µL of the collected medium and incubating at room temperature for 15 min, the absorbance was measured at 540 nm. Sodium nitrite (NaNO 2 ) standard solution was diluted by different concentrations to make a standard curve, and the NO content in each sample was calculated. The stop soluation of 50 µL was added to terminate the reaction. IL-6
Interleukin 6 (IL-6) and tumor necrosis factor (TNF-毩) measurement
and TNF-毩 conents were determined using ELISA reader at 570 nm and 450 nm, and the the amount of IL-6 and TNF-毩 contained in the samples was calculated based on the standard curve.
Statistical analysis
All measurements were expressed as mean 依 SD and statistical analysis was performed using the SPSS software package (Ver. 17).
All results were compared using one-way ANOVA analysis and significance was shown at the P < 0.05 level.
Results
Effect of aronia leaf extract on SK-Hep1 cell proliferative activity
To investigate the effect of aronia leaf on SK-Hep1 cell proliferation, the exract was diluted to various concentrations (0-400 µg/mL) and 
Effect of aronia leaf extract on migration
As shown in Figure 2 , the migration distance of cancer cells was shorter as the concentration of aronia leaf extract was higher and the incubation time was longer. There was dose dependent inhibition of migration distance with 70.6%-98.4% wound size inhibtion after treating 50-200 µg/mL of aronia leaf extract for 12 h. In the case of treatement with 100 µg/mL aronia leaf extract, the mobility of SKHep1 cells was controlled in proportion to the treated time, and the wound size in cells cultured for 12, 24 and 48 h were 91.5%, 89.6% and 76.3%. As the treated time of aronia leaf extreact increased, the cells recovered mobility.
Effect of aronia leaf extract on MMP
As shown in Figure 3 , cell culture media were collected and separated the MMP-2 and MMP-9 protein with gelatin zymography. 
Effect of aronia leaf extract on mRNA MMP and MT1-MMP
The mRNA expression of MT1-MMP, MMP-2, and MMP-9
decreased as the concentration of aronia leaf extract increased ( Figure 4) . The MMP-9 mRNA expression was reduced by 34.7%
and 63.3%, respectively, in samples treated with 50 and 100 µg/mL of aronia leaf extracts compared to the control. The MMP-2 mRNA expression was inhibited by 32.4% and 50.0%, respectively, in the same concentration of aronia leaf treatment. When 200 µg/mL of aronia leaf extract was treated, the MMP-2 mRNA expression was completely inhibited. The expression of MMP-9 mRNA in leaf extracts was much higher than that of MMP-2 mRNA. The MT-1 MMP expression was reduced by 5.3%, 15.8% and 31.6% compared to the control group after SK-Hep1 cells were treated with 50, 100, and 200 µg/mL of aronia leaf extracts for 24 h.
Effect of aronia leaf extract on Raw 264.7 cell proliferation
The degree of inhibition of Raw 264.7 cell proliferation was measured ( Figure 5 ). The concentration of aronia leaf extract up to 400 µg/mL used in this experiment did not increase or inhibit the survial of Raw 264.7 cells.
Effects of aronia leaf extract on NO production
Raw 264.7 cells with LPS (1 µg/mL) stimulation were treated with aronia leaf extract (50-200 µg/mL) and cultured for 12 h to determine NO content. NO production that was in control and LPS treated without aronia leaf extract was 30.3 and 96.6 µM, respectively. It appeared that aronia leaf extract had potential to inhibit LPS-induced production of NO compared to the LPS-treated control in Raw 264.7
cells. Aronia leaf extract at 50, 100, and 200 µg/mL suppressed the production of NO to 85.2, 70.5, and 58.2 µM, respectively in a dose dependent manner.
TNF-毩 and IL-6 measurement
The Raw 264.7 cells were inoculated with aronia leaf extract of 0-200 µg/mL and cultured for 12 h. As the concentration of aronia leaf extract increased, TNF-毩and IL-6 expression decreased, especially IL-6. These expressions showed aronia leaf extract inhibited the proinflammatory mediators in a dose dependent manner ( Figure 6 ).
TNF-毩 production that was in control and LPS treated without 
Discussion
The anticancer activity of aronia leaf extract was investigated by the multiple cellular mechanism assays. The extract of aronia leaf and systemic lupus erythematosus [24, 25] . LPS activiates a wide variety of transcription factors and induces a number of genes that are expressed during inflammation [26] . IL-6 induces inflammation and is actually found in serum and tumors of cancer cells and cancer patients [18] . IL-6 has the ability to promote tumors and, in fact, it is known that the increase in IL-6 expression is related to the growth of aggressive tumor cells in most cancers [27, 28] . Therefore, inhibition of cancer cell growth and progression is necessary to discover and develop a substance that inhibits IL-6 or IL-6 receptor [18] . Our results indicate that aronia leaf extract inhibits growth and inflammation of cancer cells. These suggest that aronia leaf can be used as a candidate for the development of cancer and inflammation inhibitory food supplement or drug.
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